- Investing Ideas
- Global Pharmaceuticals & Biotech Undervalued Small Caps
Global Pharmaceuticals & Biotech Undervalued Small Caps
Results
19
Undervalued Small Caps
19 companies
Zevra Therapeutics
Market Cap: US$665.0m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.00
7D
8.2%
1Y
41.2%
AddLife
Market Cap: SEK 17.4b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 145.70
7D
2.0%
1Y
-22.6%
Consun Pharmaceutical Group
Market Cap: HK$12.9b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.29
7D
-5.7%
1Y
60.3%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €200.9m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€8.06
7D
-12.8%
1Y
7.2%
Abeona Therapeutics
Market Cap: US$341.9m
A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
ABEO
US$5.77
7D
5.7%
1Y
5.1%
Clinuvel Pharmaceuticals
Market Cap: AU$477.6m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$9.47
7D
3.3%
1Y
-16.3%
Genomma Lab Internacional. de
Market Cap: Mex$16.7b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
LAB B
Mex$17.09
7D
3.7%
1Y
-20.0%
Blau Farmacêutica
Market Cap: R$2.4b
A pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.
BLAU3
R$10.44
7D
4.1%
1Y
5.6%
Selvita
Market Cap: zł589.2m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł31.60
7D
-9.7%
1Y
-9.5%
AcrobiosystemsLtd
Market Cap: CN¥7.7b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.
301080
CN¥45.99
7D
2.9%
1Y
37.3%
Strides Pharma Science
Market Cap: ₹106.6b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.
STAR
₹1,156.90
7D
11.6%
1Y
81.2%
Faes Farma
Market Cap: €1.5b
Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.
FAE
€4.82
7D
-0.8%
1Y
12.4%
Imexpharm
Market Cap: ₫7.4t
Operates as a pharmaceutical company in Vietnam.
IMP
₫48,100.00
7D
-5.3%
1Y
-2.4%
Bora Pharmaceuticals
Market Cap: NT$53.2b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$419.00
7D
2.7%
1Y
-30.1%
Kuros Biosciences
Market Cap: CHF 802.3m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 20.12
7D
-0.8%
1Y
-16.2%
Bonesupport Holding
Market Cap: SEK 15.1b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 228.60
7D
3.6%
1Y
-20.8%
SIGA Technologies
Market Cap: US$337.1m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$4.73
7D
2.8%
1Y
-13.1%
MedCap
Market Cap: SEK 7.6b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout.
MCAP
SEK 509.00
7D
6.1%
1Y
13.7%
Akums Drugs and Pharmaceuticals
Market Cap: ₹85.3b
Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally.
AKUMS
₹557.10
7D
1.8%
1Y
10.4%